VSTS — Vestis Corporation · 2026-09-04 · Verdict: WATCH · Conviction 2

Price $12.54 (screen row, universe_under2b.csv, dated 2026-09-04; no live quote available) · Mkt cap $1.657B · EV ~$2.86B · EV/FY26 guided Adj. EBITDA 9.2x · EV/TTM GAAP EBIT 29x · FCF yield 9.7-10.3% on guidance · Net debt $1,205.4M (4.10x) · ADV $18.5M Sources read: 10-K filed 2025-12-02 (Items 1, 1A, 7), 10-Q filed 2026-08-11 (Q3 FY26, ended 2026-07-03), DEF 14A filed 2026-01-08, 8-Ks 2026-05-12, 2026-06-15, 2026-08-11 (with EX-99.2 deck), Form 4s trailing 12 months.

1. What the business actually does

Vestis rents and launders uniforms, mats, towels and linens and supplies restrooms, first aid and safety products to more than 300,000 accounts in the US and Canada, from over 325 plants and 3,300 routes with about 18,150 employees (10-K 2025, Item 1). Ninety-five percent of revenue is recurring route servicing under multi-year contracts; the top ten customers are under 10% of revenue. It was spun from Aramark on 2023-09-30 with a $1,457 million cash distribution to the parent, which is where the debt came from (Item 7). Cintas and UniFirst are the named larger competitors; about 60% of uniforms are made in two company plants in Mexico.

2. Why it is mispriced — the edge case

Post-restructuring, and the screen row is stale rather than wrong: it shows 41.7x EV/EBIT and a 0.3% FCF yield on fiscal 2025's $64.4 million of operating income, while fiscal 2026 is now guided to $310-315 million of Adjusted EBITDA and $160-170 million of free cash flow against fiscal 2025 actuals of $272.6 million and $5.9 million (8-K 2026-08-11, EX-99.1).

The honest answer, though, is that the edge has largely closed. The same screen row shows 12-minus-1 momentum of +219.5%, a six month return of +55.6%, and the stock only 24% off its 52-week high. The forced sellers from the fiscal 2025 collapse are gone, the early buyers have been paid, and I cannot name a seller today who is wrong or indifferent.

3. Unit economics and growth

Fiscal 2025 was ugly: revenue down 4.4% excluding the 53rd week, lost business exceeding new business by $69.9 million, operating income down 59.2% (10-K, Item 7). Fiscal 2026 is the cost mirror image. Nine month operating income is $80.6 million against $46.8 million on revenue down 1.9%, driven by SG&A down $44.0 million including $25.4 million less in salaries and wages (10-Q, Item 2). Q3 Adjusted EBITDA was $80.9 million at a 12.2% margin, up 23% on the prior year's comparable $65.8 million. US segment margin went 6.6% to 9.2%; Canada, 9% of revenue, slipped 4.2% to 3.9% (10-Q).

The metric that matters is per pound. In Q3 volume fell 4.5% to 467.3 million pounds while revenue per pound rose 2.9% to $1.42 and cost per pound held flat at $1.24, lifting operating leverage per pound from $0.14 to $0.18, the company's first year-over-year revenue-per-pound increase as a public company (EX-99.2, slides 6-7). Management attributes part of the volume loss to deliberately shedding unprofitable linen: linen volume was +7% in Q1, +4% in Q2, then -6% in Q3. Credible for a quarter or two, but not yet distinguishable from ordinary attrition, and no retention rate is disclosed.

4. Balance sheet and capital allocation

Principal debt is $1,097.5 million (Term Loan A-2 $700M due 2028, Term Loan B-1 $800M due 2031) plus $159.7 million of finance leases and $5.8 million of letters of credit, less $57.7 million cash: company-defined Net Debt of $1,205.4 million and 4.10x leverage, down from 4.72x at year end (8-K 2026-08-11). The covenant steps to 4.75x in October 2026 and 4.50x from Q1 fiscal 2027, after a May 2025 amendment that had loosened it to 5.25x; that amendment also bars all dividends and buybacks until compliance after 2026-10-02 or 4.50x for two consecutive quarters (10-Q). So no buyback, no dividend, share count flat at 132.2 million.

Off balance sheet, $212.3 million of receivables are sold under a facility terminating 2027-08-02 that cost $12.2 million of fees in twelve months, a real cash cost excluded from Adjusted EBITDA. Corvex owns 15.0% and Keith Meister sits on the board; BlackRock, FMR, AIMCo and Vanguard hold another 37% (DEF 14A). CEO Jim Barber bought 84,500 shares at $12.37 on 2026-09-02 for $1,045,383, the only open market insider trade in twelve months (Form 4, 2026-09-02).

5. Management: said versus did

Governance has been chaotic and costly. Kim Scott left as CEO in fiscal 2025 with $8,417,345 of severance and benefits; the board chair served as interim; Barber was hired externally with a 478,469 unit RSU grant on 2025-06-02 (DEF 14A). There has been no permanent CFO since 2025-12-16, and on 2026-06-12 the company agreed to pay interim CFO Adam Bowen $100,000 for every further three month period without one (8-K 2026-06-15), which is not a company expecting to fill the seat soon.

Delivery has been good. Fiscal 2026 Adjusted EBITDA guidance went $285-315M, then $295-325M, then $310-315M; free cash flow went $50-60M, then $120-150M, then $160-170M (8-K 2026-05-12 deck; 8-K 2026-08-11). Nine month free cash flow is $120.8 million against negative $9.8 million. Part is working capital, not earnings: operating working capital fell from $206.1 million to $173.1 million over four quarters, and that roughly $33 million does not repeat.

6. Valuation

Base (50%): the $75 million of annualized savings plus $10 million of fiscal 2027 outsourcing savings land, volume flattens, fiscal 2027 Adjusted EBITDA about $330 million at 8.5x, net debt about $1.07 billion, equity about $13.2 a share. Bear (25%): the 4.5% volume decline is attrition, price cannot outrun it, EBITDA settles near $280 million at 7.5x with leverage back near 4.5x, about $7.2. Bull (25%): margin reaches 13.5-14%, EBITDA about $360 million, buybacks restart, 10.5x, about $18. Probability weighted, about $12.9 against $12.54: a 3% margin of safety, which is none. Reverse DCF: at $12.54 the $2.86 billion enterprise value is roughly 18x my estimate of fiscal 2026 unlevered free cash flow of about $155 million (guided Adjusted EBITDA less securitization fees, less about $95 million of capital investments including new finance leases, taxed at 25%), which at a 9% cost of capital implies about 3.5% perpetual growth from a business whose pounds processed fell 4.5% last quarter.

7. Catalysts and timeline

Q4 results and fiscal 2027 guidance in early December 2026 (Q4 Adjusted EBITDA already implied at $84-89 million); the dividend and buyback restriction potentially lifting after the quarter ending 2026-10-02; a permanent CFO; A/R facility renewal before August 2027.

8. Risks and pre-registered kill criteria

Risks: 10,750 of 18,150 employees are unionized with multiemployer pension withdrawal exposure; a securities class action is pending; a goodwill impairment triggering event already occurred in fiscal 2025 with no charge taken and the risk stays live (10-Q); Mexican manufacturing sits inside a tariff regime the company flags (Item 1A). Kill criteria: 1. Pounds processed down more than 4% year over year in any quarter after fiscal Q1 2027, once the linen shedding has lapped. 2. Net leverage above 4.50x at any quarter end from Q1 fiscal 2027, or any further covenant amendment. 3. Fiscal 2027 Adjusted EBITDA guidance below $330 million when issued. 4. No permanent CFO named by the fiscal 2026 10-K filing, or any open market sale by Barber.

9. Verdict and summary

WATCH, conviction 2. Vestis is a real post-spin turnaround that is working: cost per pound flat while revenue per pound rose 2.9%, US segment margin from 6.6% to 9.2%, Adjusted EBITDA up 23%, nine month free cash flow from negative $9.8 million to $120.8 million, leverage from 4.72x to 4.10x, and a new CEO who put $1.045 million of his own money in at $12.37 two days ago. The problem is that the market already knows: the stock is up 219.5% over twelve months and sits 24% off its high, so at $12.54 the $2.86 billion enterprise value is 9.2x guidance management has raised three times this year, and my probability weighted value of $12.9 sits 3% above the price. Underneath, volume is still falling 4.5%, about $33 million of this year's cash came from working capital that will not repeat, $12 million a year of securitization fees sit outside Adjusted EBITDA, and there has been no permanent CFO for nine months. Buy it when volume stops falling or the price does, not because the transformation is real, which it plainly is.

Research for discussion, not investment advice. Positions and sizing are the reader's decision.